SC 13G/A | 2022-02-15 | Rock Springs Capital Management LP | FIVE PRIME THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2021-05-17 | RA CAPITAL MANAGEMENT, L.P. | FIVE PRIME THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13D | 2021-03-15 | Magnetar Financial LLC | FIVE PRIME THERAPEUTICS, INC. | 2,443,768 | 5.3% | EDGAR |
SC 13G/A | 2021-03-08 | BIOTECHNOLOGY VALUE FUND L P | FIVE PRIME THERAPEUTICS, INC. | 3,372,098 | 7.3% | EDGAR |
SC 13G | 2021-03-01 | Rock Springs Capital Management LP | FIVE PRIME THERAPEUTICS, INC. | 3,041,559 | 6.9% | EDGAR |
SC 13G | 2021-02-16 | RA CAPITAL MANAGEMENT, L.P. | FIVE PRIME THERAPEUTICS, INC. | 4,285,161 | 9.8% | EDGAR |
SC 13G | 2021-02-16 | RTW INVESTMENTS, LP | FIVE PRIME THERAPEUTICS, INC. | 2,515,788 | 5.7% | EDGAR |
SC 13G | 2021-02-02 | BlackRock Inc. | FIVE PRIME THERAPEUTICS, INC. | 2,959,031 | 6.7% | EDGAR |
SC 13G | 2021-02-01 | BIOTECHNOLOGY VALUE FUND L P | FIVE PRIME THERAPEUTICS, INC. | 1,657,243 | 3.8% | EDGAR |
SC 13G | 2020-12-08 | BlackRock Inc. | FIVE PRIME THERAPEUTICS, INC. | 2,125,177 | 4.8% | EDGAR |
SC 13D/A | 2020-11-13 | BIOTECHNOLOGY VALUE FUND L P | FIVE PRIME THERAPEUTICS, INC. | 670,695 | 1.8% | EDGAR |
SC 13D/A | 2020-10-08 | BIOTECHNOLOGY VALUE FUND L P | FIVE PRIME THERAPEUTICS, INC. | 4,336,875 | 11.8% | EDGAR |
SC 13G/A | 2020-02-14 | GREAT POINT PARTNERS LLC | FIVE PRIME THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-05 | BlackRock Inc. | FIVE PRIME THERAPEUTICS, INC. | 2,535,819 | 7.0% | EDGAR |
SC 13D | 2019-12-27 | BIOTECHNOLOGY VALUE FUND L P | FIVE PRIME THERAPEUTICS, INC. | 3,929,792 | 10.8% | EDGAR |
SC 13G/A | 2019-12-09 | WELLINGTON MANAGEMENT GROUP LLP | FIVE PRIME THERAPEUTICS, INC. | 1,280,750 | 3.5% | EDGAR |
SC 13G/A | 2019-11-12 | FMR LLC | FIVE PRIME THERAPEUTICS, INC. | 500 | 0.0% | EDGAR |
SC 13G/A | 2019-11-08 | BIOTECHNOLOGY VALUE FUND L P | FIVE PRIME THERAPEUTICS, INC. | 2,958,503 | 8.1% | EDGAR |
SC 13G/A | 2019-10-02 | BIOTECHNOLOGY VALUE FUND L P | FIVE PRIME THERAPEUTICS, INC. | 2,046,311 | 5.6% | EDGAR |
SC 13G/A | 2019-07-10 | FMR LLC | FIVE PRIME THERAPEUTICS INC | 1,808,684 | 5.0% | EDGAR |